SAShaden D. Alshehri

Shaden D. Alshehri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaden D. Alshehri has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Outcomes After Operative and Nonoperative Management of Hamstring Injuries: A Systematic Review

    by Khalid M. Alhomayani, Rinad H. AlSayed, Danah O. Sandaqji, Abdulwahab A. Alharbi, Osama H. AlSayed, Alya A. Alshammary, Shaden D. Alshehri, Hashem A. Bukhary

    Background: Hamstring injuries are common in sports involving rapid acceleration and directional changes. Despite extensive research, management remains primarily dependent on clinical judgment, owing to the absence of standardized, evidence-based protocols. Purpose: To compare the outcomes of operative versus nonoperative treatments, focusing on patient satisfaction, muscle strength, range of motion (ROM), activity level, and return to sport. Study Design: Systematic review; Level of evidence, 4. Methods: Using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, the authors performed a systematic search of the PubMed, Google Scholar, Web of Science, and ScienceDigest databases from January 2000 to May 2024. Reported outcomes measured were muscle strength, ROM, functional activity, pain levels, return to preinjury activity levels, and patient satisfaction. Additionally, any complications related to the intervention were documented. The authors identified 13 eligible studies involving adults with acute hamstring injuries, including 526 patients. Eleven studies specifically investigated operative treatment, 1 examined nonoperative management, and 1 directly compared both approaches. Result: Surgical intervention was consistently associated with superior outcomes across multiple domains. Postoperatively, the Lower Extremity Functional Scale score often exceeded 74, and strength recovery commonly approached 90.0% of the contralateral limb. ROM was preserved after surgery but was not evaluated in nonoperative cohorts. Functional activity was generally higher after operative treatment (mean Tegner Activity Scale [TAS] scores: 4.7 ± 0.8, 6.0 ± 1.47, 5.1, and 8.5 ± 2.4; Marx Activity Rating Scale scores: 3.5 ± 4.3 and 4.4 ± 4.4), whereas nonoperative treatment showed a decline in TAS score (6.9 ± 1.7 to 6.1 ± 1.9; P = .030). Pain levels were low overall (visual analog scale score: 0.7 ± 0.9 to 4.0 ± 4.0). Complications were more frequent after surgery (4.2%-36.6%, including hematomas, neurapraxia, and superficial infections), although mostly minor. Nonoperative complications were limited to ecchymosis. Conclusion: This study demonstrated that operative treatment was associated with good functional recovery, muscle strength, and high return-to-sport rates. Complications rates within the operative group were mostly minor and not statistically significant when compared to nonoperative management, which yielded good outcomes in the limited available data. Further prospective studies using standardized outcome measures and clear subtype definitions are required to determine which patients benefit most from operative versus nonoperative management.

  • Open Access

    Calcium Channel Blocker Toxicity: A Practical Approach

    by Omar A Alshaya, Arwa Alhamed, Sara Althewaibi, Lolwa Fetyani, Shaden Alshehri, Fai Alnashmi, Shmeylan Alharbi, Mohammed Alrashed, Saleh F Alqifari, Abdulrahman I Alshaya

    Calcium channel blockers (CCBs) are widely prescribed medications for various clinical indications in adults and children. They are available in both immediate and long-acting formulations and are generally classified into dihydropyridines and nondihydropyridines, with nondihydropyridines having more cardioselectivity. CCB toxicity is common given the widespread use which leads to serious adverse clinical outcomes, especially in children. Severe CCB toxicities may present with life-threatening bradycardia, hypotension, hyperglycemia, and renal insufficiency. Dihydropyridine toxicity, however, may present with reflex tachycardia instead of bradycardia. Initial patient evaluation and assessment are crucial to identify the severity of CCB toxicity and design the best management strategy. There are different strategies to overcome CCB toxicity that requires precise dosing and close monitoring in various patient populations. These strategies may include large volumes of IV fluids, calcium salts, high insulin euglycemia therapy (HIET), and vasopressors. We hereby summarize the evidence behind the management of CCB toxicity and present a practical guide for clinicians to overcome this common drug toxicity.